A phase i dose-escalation study of the immunocytokine EMD 521873 (Selectikine) in patients with advanced solid tumours

Silke Gillessen, Ulrike S. Gnad-Vogt, Elisa Gallerani, Joachim Beck, Cristiana Sessa, Aurelius Omlin, Maria R. Mattiacci, Bernd Liedert, Daniel Kramer, Julien Laurent, Daniel E. Speiser, Roger Stupp*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

25 Scopus citations

Fingerprint Dive into the research topics of 'A phase i dose-escalation study of the immunocytokine EMD 521873 (Selectikine) in patients with advanced solid tumours'. Together they form a unique fingerprint.

Medicine & Life Sciences